Oncology has risen to the forefront of genomic profiling, which is being used to identify actionable driver mutations and other markers. These markers can...
New funding will allow for the global commercialization of the company's Breath Biopsy technology which measures volatile organic compounds
The new Chromium™ Single Cell V(D)J Solution allows the profiling of paired V(D)J transcripts from hundreds to millions of lymphocytes.
The program at Hermitage Medical Center is part of Sanford World Clinic which seeks to bring genomic cancer care to patients worldwide
Researchers say vapers have higher levels of some DNA-damaging compounds in their saliva, and DNA damage consistent with those compounds
Mutations can frequently vary between biopsies, with 19% of patients harboring more than one type of genetic resistance to treatment.
GeneDx’ subsidiary BioReference Laboratories published results in Genetics in Medicine from a retrospective review of molecular diagnostic testing by whole exome sequencing (WES). According...
Prostate cancer is a relatively common disease with high morbidity and mortality; it is expected to kill more than 27,000 men this year in...
Company will use its Precision Metabolomics technology to analyze samples, with the aim of identifying biomarkers of wellness and disease
The company says its test is the first capture-based myeloid genomic test to receive a CE-IVD mark